Your browser doesn't support javascript.
loading
A metabolic profile of xenon and metabolite associations with 6-month mortality after out-of-hospital cardiac arrest: A post-hoc study of the randomised Xe-Hypotheca trial.
Nummela, Aleksi J; Scheinin, Harry; Perola, Markus; Joensuu, Anni; Laitio, Ruut; Arola, Olli; Grönlund, Juha; Roine, Risto O; Bäcklund, Minna; Vahlberg, Tero J; Laitio, Timo.
Afiliação
  • Nummela AJ; Department of Internal Medicine, Turku University Hospital, University of Turku, Turku, Finland.
  • Scheinin H; Department of Perioperative Services, Intensive Care and Pain Management, Turku University Hospital, University of Turku, Turku, Finland.
  • Perola M; Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.
  • Joensuu A; Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Laitio R; Faculty of Medicine, Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland.
  • Arola O; Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Grönlund J; Faculty of Medicine, Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland.
  • Roine RO; Department of Perioperative Services, Intensive Care and Pain Management, Turku University Hospital, University of Turku, Turku, Finland.
  • Bäcklund M; Department of Perioperative Services, Intensive Care and Pain Management, Turku University Hospital, University of Turku, Turku, Finland.
  • Vahlberg TJ; Department of Perioperative Services, Intensive Care and Pain Management, Turku University Hospital, University of Turku, Turku, Finland.
  • Laitio T; Division of Clinical Neurosciences, University of Turku, Turku University Hospital, Turku, Finland.
PLoS One ; 19(6): e0304966, 2024.
Article em En | MEDLINE | ID: mdl-38833442
ABSTRACT

PURPOSE:

Out-of-hospital cardiac arrest (OHCA) carries a relatively poor prognosis and requires multimodal prognostication to guide clinical decisions. Identification of previously unrecognized metabolic routes associated with patient outcome may contribute to future biomarker discovery. In OHCA, inhaled xenon elicits neuro- and cardioprotection. However, the metabolic effects remain unknown. MATERIALS AND

METHODS:

In this post-hoc study of the randomised, 2-group, single-blind, phase 2 Xe-Hypotheca trial, 110 OHCA survivors were randomised 11 to receive targeted temperature management (TTM) at 33°C with or without inhaled xenon during 24 h. Blood samples for nuclear magnetic resonance spectroscopy metabolic profiling were drawn upon admission, at 24 and 72 h.

RESULTS:

At 24 h, increased lactate, adjusted hazard-ratio 2.25, 95% CI [1.53; 3.30], p<0.001, and decreased branched-chain amino acids (BCAA) leucine 0.64 [0.5; 0.82], p = 0.007, and valine 0.37 [0.22; 0.63], p = 0.003, associated with 6-month mortality. At 72 h, increased lactate 2.77 [1.76; 4.36], p<0.001, and alanine 2.43 [1.56; 3.78], p = 0.001, and decreased small HDL cholesterol ester content (S-HDL-CE) 0.36 [0.19; 0.68], p = 0.021, associated with mortality. No difference was observed between xenon and control groups.

CONCLUSIONS:

In OHCA patients receiving TTM with or without xenon, high lactate and alanine and decreased BCAAs and S-HDL-CE associated with increased mortality. It remains to be established whether current observations on BCAAs, and possibly alanine and lactate, could reflect neural damage via their roles in the metabolism of the neurotransmitter glutamate. Xenon did not significantly alter the measured metabolic profile, a potentially beneficial attribute in the context of compromised ICU patients. TRIAL REGISTRATION Trial Registry number ClinicalTrials.gov Identifier NCT00879892.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Xenônio / Parada Cardíaca Extra-Hospitalar Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Finlândia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Xenônio / Parada Cardíaca Extra-Hospitalar Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Finlândia